{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T02:23:31Z","timestamp":1720405411639},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.schres.2017.07.041","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T11:47:05Z","timestamp":1501069625000},"page":"154-160","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A computational network analysis based on targets of antipsychotic agents"],"prefix":"10.1016","volume":"193","author":[{"given":"Lei","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiu-qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke-ke","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.schres.2017.07.041_bb0005","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/clpt.2010.91","article-title":"Network systems biology for drug discovery","volume":"88","author":"Arrell","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.schres.2017.07.041_bb0010","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/bioinformatics\/btm554","article-title":"Computing topological parameters of biological networks","volume":"24","author":"Assenov","year":"2008","journal-title":"Bioinformatics"},{"issue":"19","key":"10.1016\/j.schres.2017.07.041_bb0015","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1093\/bioinformatics\/btp465","article-title":"Network analyses in systems pharmacology","volume":"25","author":"Berger","year":"2009","journal-title":"Bioinformatics"},{"issue":"8","key":"10.1016\/j.schres.2017.07.041_bb0020","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.schres.2017.07.041_bb0025","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/npp.2015.5","article-title":"Variation in dopamine D2 and serotonin 5-HT2A receptor genes is associated with working memory processing and response to treatment with antipsychotics","volume":"40","author":"Blasi","year":"2015","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.schres.2017.07.041_bb0030","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5498\/wjp.v6.i1.66","article-title":"Systems psychopharmacology: a network approach to developing novel therapies","volume":"6","author":"Gebicke-Haerter","year":"2016","journal-title":"World Journal of Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.07.041_bb0035","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.schres.2015.02.001","article-title":"Integration of gene expression and GWAS results supports involvement of calcium signaling in schizophrenia","volume":"164","author":"Hertzberg","year":"2015","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2017.07.041_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"Huang da","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.schres.2017.07.041_bb0045","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat. Protoc."},{"issue":"5","key":"10.1016\/j.schres.2017.07.041_bb0050","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/clpt.2008.129","article-title":"Identification of information flow-modulating drug targets: a novel bridging paradigm for drug discovery","volume":"84","author":"Hwang","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.schres.2017.07.041_bb0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fncel.2015.00261","article-title":"Functional alterations of astrocytes in mental disorders: pharmacological significance as a drug target","volume":"9","author":"Koyama","year":"2015","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.schres.2017.07.041_bb0060","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1503\/jpn.120133","article-title":"Cytochrome P450-mediated drug metabolism in the brain","volume":"38","author":"Miksys","year":"2013","journal-title":"Journal of Psychiatry & Neuroscience: JPN"},{"issue":"3","key":"10.1016\/j.schres.2017.07.041_bb0065","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.mehy.2009.04.003","article-title":"Loss of function of glial gap junctions may cause severe cognitive impairments in schizophrenia","volume":"73","author":"Mitterauer","year":"2009","journal-title":"Med. Hypotheses"},{"issue":"12","key":"10.1016\/j.schres.2017.07.041_bb0070","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/mp.2012.47","article-title":"Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents","volume":"17","author":"Miyamoto","year":"2012","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2017.07.041_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094328","article-title":"Network analysis of inflammatory genes and their transcriptional regulators in coronary artery disease","volume":"9","author":"Nair","year":"2014","journal-title":"PloS one"},{"issue":"1","key":"10.1016\/j.schres.2017.07.041_bb0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/nar\/27.1.29","article-title":"KEGG: Kyoto Encyclopedia of Genes and Genomes","volume":"27","author":"Ogata","year":"1999","journal-title":"Nucleic Acids Res."},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.07.041_bb0085","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.schres.2012.08.003","article-title":"DRD1 rs4532 polymorphism: a potential pharmacogenomic marker for treatment response to antipsychotic drugs","volume":"142","author":"Ota","year":"2012","journal-title":"Schizophr. Res."},{"issue":"10039","key":"10.1016\/j.schres.2017.07.041_bb0090","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","article-title":"Schizophrenia","volume":"388","author":"Owen","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.schres.2017.07.041_bb0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/tpj.2008.5","article-title":"DRD4 48bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain","volume":"9","author":"Popp","year":"2009","journal-title":"Pharmacogenomics J."},{"issue":"2","key":"10.1016\/j.schres.2017.07.041_bb0100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/cmb.2005.12.113","article-title":"Analyzing protein lists with large networks: edge-count probabilities in random graphs with given expected degrees","volume":"12","author":"Pradines","year":"2005","journal-title":"Journal of Computational Biology: A Journal of Computational Molecular Cell Biology"},{"issue":"7256","key":"10.1016\/j.schres.2017.07.041_bb0105","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nature08185","article-title":"Common polygenic variation contributes to risk of schizophrenia and bipolar disorder","volume":"460","author":"Purcell","year":"2009","journal-title":"Nature"},{"issue":"7487","key":"10.1016\/j.schres.2017.07.041_bb0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature12975","article-title":"A polygenic burden of rare disruptive mutations in schizophrenia","volume":"506","author":"Purcell","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.schres.2017.07.041_bb0115","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0163-7258(98)00019-9","article-title":"5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function","volume":"79","author":"Roth","year":"1998","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.schres.2017.07.041_bb0120","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3389\/fphys.2015.00371","article-title":"Historeceptomic fingerprints for drug-like compounds","volume":"6","author":"Shmelkov","year":"2015","journal-title":"Front. Physiol."},{"issue":"2","key":"10.1016\/j.schres.2017.07.041_bb0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1017\/S1092852900000213","article-title":"Multifunctional drugs: a novel concept for psychopharmacology","volume":"14","author":"Stahl","year":"2009","journal-title":"CNS Spectr."},{"key":"10.1016\/j.schres.2017.07.041_bb0130","doi-asserted-by":"crossref","first-page":"458989","DOI":"10.1155\/2013\/458989","article-title":"Characterization of schizophrenia adverse drug interactions through a network approach and drug classification","volume":"2013","author":"Sun","year":"2013","journal-title":"Biomed. Res. Int."},{"issue":"Database issue","key":"10.1016\/j.schres.2017.07.041_bb0135","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gku1003","article-title":"STRING v10: protein\u2013protein interaction networks, integrated over the tree of life","volume":"43","author":"Szklarczyk","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.schres.2017.07.041_bb0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/187152706784111614","article-title":"Dopamine receptor pharmacology: interactions with serotonin receptors and significance for the aetiology and treatment of schizophrenia","volume":"5","author":"Werkman","year":"2006","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"6","key":"10.1016\/j.schres.2017.07.041_bb0145","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/schbul\/sbv116","article-title":"Association of a schizophrenia risk variant at the DRD2 locus with antipsychotic treatment response in first-episode psychosis","volume":"41","author":"Zhang","year":"2015","journal-title":"Schizophr. Bull."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417304528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417304528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T12:49:31Z","timestamp":1569934171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996417304528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":29,"alternative-id":["S0920996417304528"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2017.07.041","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A computational network analysis based on targets of antipsychotic agents","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2017.07.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}